source Post navigation Franciscan Health offering Virtual Diabetes Prevention Program – WIMS AM 1420 Expert: Approval of Semaglutide Major Advancement for CKD, Cardiovascular Risk Reduction in Type 2 Diabetes – Pharmacy Times